High-dose influenza vaccines make economic sense for older people

被引：1
|
作者：
Jit, Mark [1 ,2 ]
机构：
[1] Publ Hlth England, Modelling & Econ Unit, London NW9 5EQ, England
[2] Univ London London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England
来源：
LANCET INFECTIOUS DISEASES | 2015年 / 15卷 / 12期
关键词：
SEASONAL INFLUENZA; VACCINATION; EFFICACY; IMPACT;
D O I：
10.1016/S1473-3099(15)00272-8
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1372 / 1373
页数：2
相关论文
共 50 条
  • [21] Is the high-dose influenza vaccine better for people over age 65 years?
    Haley, Anna
    Urnoski, Eric
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2021, 34 (09): : 18 - 19
  • [22] Fluzone® High-Dose Influenza Vaccine
    Robertson, Corwin A.
    DiazGranados, Carlos A.
    Decker, Michael D.
    Chit, Ayman
    Mercer, Monica
    Greenberg, David P.
    EXPERT REVIEW OF VACCINES, 2016, 15 (12) : 1495 - 1505
  • [23] High-dose influenza vaccination in the elderly
    Foster, Stephan L.
    Moore, W. Paul
    JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION, 2010, 50 (04) : 546 - 547
  • [24] Cost-Effectiveness and Burden of Disease for Adjuvanted Quadrivalent Influenza Vaccines Compared to High-Dose Quadrivalent Influenza Vaccines in Elderly Patients in Spain
    Ruiz-Aragon, Jesus
    Marquez-Pelaez, Sergio
    Gani, Ray
    Alvarez, Piedad
    Guerrero-Luduena, Richard
    VACCINES, 2022, 10 (02)
  • [25] Effect of age on relative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries ages 65 years and older
    Lu, Yun
    Chillarige, Yoganand
    Izurieta, Hector
    Wei, Yuqin
    Xu, Wenjie
    Lu, Michael
    Sung, Heng-Meng
    Lindaas, Arnstein
    Wernecke, Michael
    MaCurdy, Thomas
    Kelman, Jeffrey
    Forshee, Richard A.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2019, 28 : 239 - 240
  • [26] The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-2022 influenza season
    Bricout, Helene
    Levant, Marie-Cecile
    Assi, Nada
    Crepey, Pascal
    Descamps, Alexandre
    Mari, Karine
    Gaillat, Jacques
    Gavazzi, Gaetan
    Grenier, Benjamin
    Launay, Odile
    Mosnier, Anne
    Raguideau, Fanny
    Watier, Laurence
    Harris, Rebecca C.
    Chit, Ayman
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (12) : 1592 - 1598
  • [27] Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010-2015
    Izurieta, Hector S.
    Chillarige, Yoganand
    Kelman, Jeffrey A.
    Forshee, Richard
    Qiang, Yandong
    Wernecke, Michael
    Ferdinands, Jill M.
    Lu, Yun
    Wei, Yuqin
    Xu, Wenjie
    Lu, Michael
    Fry, Alicia
    Pratt, Douglas
    Shay, David K.
    CLINICAL INFECTIOUS DISEASES, 2018, 67 (03) : 378 - 387
  • [28] Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty
    DiazGranados, C. A.
    Dunning, A. J.
    Robertson, C. A.
    Talbot, H. K.
    Landolfi, V.
    Greenberg, D. P.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2014, 62 : S37 - S38
  • [29] High-Dose Quadrivalent Influenza Vaccine for Prevention of Cardiovascular and Respiratory Hospitalizations in Older Adults
    Palmu, Arto A.
    Pepin, Stephanie
    Syrjaenen, Ritva K.
    Mari, Karine
    Mallett Moore, Tamala
    Jokinen, Jukka
    Nieminen, Heta
    Kilpi, Terhi
    Samson, Sandrine I.
    De Bruijn, Iris
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2024, 18 (04)
  • [30] Efficacy and immunogenicity of high-dose influenza vaccine in older adults by age, comorbidities, and frailty
    DiazGranados, Carlos A.
    Dunning, Andrew. J.
    Robertson, Corwin A.
    Talbot, H. Keipp
    Landolfi, Victoria
    Greenberg, David P.
    VACCINE, 2015, 33 (36) : 4565 - 4571
12345